Injective Protocol is a layer-1 blockchain built for finance that enables developers to build sophisticated DeFi applications. The protocol supports cross-chain derivative trading, spot trading, and other advanced financial instruments with zero gas fees. Built using the Cosmos SDK, Injective offers interoperability with Ethereum and other major blockchains. The platform aims to democratize access to DeFi by providing institutional-grade trading infrastructure that is fully decentralized and community-governed.
Injective Protocol has received investment from 1 venture capital firm.
Decentralized exchange protocol built for cross-chain derivative trading with zero gas fees.
Injective Protocol has received investment from Binance Labs. These venture capital firms and investors provide both capital and strategic support.
Injective Protocol has raised $40M in total funding, with their most recent round being a Series A. The company operates in the Web3 sector.
Injective Protocol was founded in 2018 and is headquartered in New York, NY.
Injective Protocol operates in the Web3 sector. Decentralized exchange protocol built for cross-chain derivative trading with zero gas fees.
